PT-141: Dosage, Benefits & Research Guide
Also known as: Bremelanotide, PT141
What is PT-141?
PT-141, also known as Bremelanotide, is a cyclic heptapeptide melanocortin receptor agonist derived from the alpha-melanocyte-stimulating hormone (alpha-MSH) analogue Melanotan II. Unlike PDE5 inhibitors that act on vascular smooth muscle, PT-141 operates centrally through melanocortin-4 receptor (MC4R) activation in the hypothalamus and limbic system, initiating downstream dopaminergic signaling pathways associated with arousal and sexual motivation. Phase III clinical trials conducted by Palatin Technologies and published in The Journal of Sexual Medicine demonstrated that PT-141 administration produced statistically significant increases in satisfying sexual events and desire scores in premenopausal women with hypoactive sexual desire disorder (HSDD). Research by Diamond et al. (2006) in the International Journal of Impotence Research showed efficacy in male subjects who had not responded to PDE5 inhibitor therapy, suggesting a fundamentally different mechanism of action. Additional preclinical studies have identified potential roles in hemorrhagic shock models, where MC receptor activation provided protective effects on organ perfusion. Compared to sildenafil (Viagra) and tadalafil (Cialis), which are peripherally acting vasodilators, PT-141 is unique in its central nervous system mechanism. This distinction is significant because it suggests PT-141 may address desire-based dysfunction rather than purely mechanical erectile function. Melanotan II, its parent compound, activates multiple MC receptors non-selectively, while PT-141 shows preferential MC4R and MC1R activity. Store lyophilized PT-141 at -20°C. Reconstitute with bacteriostatic water and keep at 2-8°C, using within 4 weeks. PT-141 is investigated by sexual medicine researchers, neuroendocrinologists, and emergency medicine scientists studying melanocortin-based interventions.
PT-141 Research Applications
In published and preclinical research, PT-141 has been studied across the following areas:
- Sexual dysfunction and arousal research
- Hemorrhagic protection studies
- Immune modulation via MC-1R
- DNA repair and cancer prevention
PT-141 in Research: Reconstitution & Study Concentrations
PT-141 (bremelanotide) is a cyclic melanocortin-receptor agonist studied for central nervous system pathways related to sexual-response signaling. Research concentrations are model-specific. Reconstitute the lyophilized peptide with bacteriostatic water for laboratory use only.
Worked example: a 10mg vial reconstituted with 2 mL of bacteriostatic water yields 5.00 mg/mL.
Open the reconstitution calculatorHow PT-141 Compares
Researchers frequently evaluate PT-141 alongside related compounds:
- PT-141 vs Melanotan-2 — related melanocortin agonist, pigmentation focus